| Inflammatory markers in post-traumatic stress disorder: a systematic review, meta-analysis, and meta-regression IC Passos, MP Vasconcelos-Moreno, LG Costa, M Kunz, E Brietzke, ... The Lancet Psychiatry 2 (11), 1002-1012, 2015 | 693 | 2015 |
| Brain-derived neurotrophic factor as a state-marker of mood episodes in bipolar disorders: a systematic review and meta-regression analysis BS Fernandes, CS Gama, KM Cereser, LN Yatham, GR Fries, G Colpo, ... Journal of psychiatric research 45 (8), 995-1004, 2011 | 455 | 2011 |
| Elevated serum superoxide dismutase and thiobarbituric acid reactive substances in different phases of bipolar disorder and in schizophrenia M Kunz, CS Gama, AC Andreazza, M Salvador, KM Ceresér, FA Gomes, ... Progress in Neuro-Psychopharmacology and Biological Psychiatry 32 (7), 1677-1681, 2008 | 305 | 2008 |
| Serum levels of IL-6, IL-10 and TNF-α in patients with bipolar disorder and schizophrenia: differences in pro-and anti-inflammatory balance M Kunz, KM Ceresér, PD Goi, GR Fries, AL Teixeira, BS Fernandes, ... Brazilian Journal of Psychiatry 33, 268-274, 2011 | 268 | 2011 |
| Staging systems in bipolar disorder: an I nternational S ociety for B ipolar D isorders T ask F orce R eport F Kapczinski, PVS Magalhães, V Balanzá‐Martinez, VV Dias, S Frangou, ... Acta psychiatrica scandinavica 130 (5), 354-363, 2014 | 247 | 2014 |
| The role of BDNF as a mediator of neuroplasticity in bipolar disorder I Grande, GR Fries, M Kunz, F Kapczinski Psychiatry investigation 7 (4), 243, 2010 | 214 | 2010 |
| Serum levels of brain-derived neurotrophic factor in patients with schizophrenia and bipolar disorder CS Gama, AC Andreazza, M Kunz, M Berk, PS Belmonte-de-Abreu, ... Neuroscience letters 420 (1), 45-48, 2007 | 201 | 2007 |
| Increased oxidative stress and DNA damage in bipolar disorder: a twin-case report BN Frey, AC Andreazza, M Kunz, FA Gomes, J Quevedo, M Salvador, ... Progress in Neuro-Psychopharmacology and Biological Psychiatry 31 (1), 283-285, 2007 | 177 | 2007 |
| Improvement of negative and positive symptoms in treatment-refractory schizophrenia: a double-blind, randomized, placebo-controlled trial with memantine as add-on therapy to … D de Lucena, BS Fernandes, M Berk, S Dodd, DW Medeiros, M Pedrini, ... The Journal of clinical psychiatry 70 (10), 8775, 2009 | 157 | 2009 |
| Predominant polarity in bipolar disorder: diagnostic implications AR Rosa, AC Andreazza, M Kunz, F Gomes, A Santin, J Sanchez-Moreno, ... Journal of affective disorders 107 (1-3), 45-51, 2008 | 146 | 2008 |
| Staging and neuroprogression in bipolar disorder: a systematic review of the literature CS Gama, M Kunz, PVS Magalhães, F Kapczinski Brazilian Journal of Psychiatry 35, 70-74, 2013 | 145 | 2013 |
| Mediators of allostasis and systemic toxicity in bipolar disorder I Grande, PV Magalhães, M Kunz, E Vieta, F Kapczinski Physiology & behavior 106 (1), 46-50, 2012 | 141 | 2012 |
| Mitochondrial activity and oxidative stress markers in peripheral blood mononuclear cells of patients with bipolar disorder, schizophrenia, and healthy subjects C Gubert, L Stertz, B Pfaffenseller, BS Panizzutti, GT Rezin, R Massuda, ... Journal of psychiatric research 47 (10), 1396-1402, 2013 | 128 | 2013 |
| Staging and neuroprogression in bipolar disorder GR Fries, B Pfaffenseller, L Stertz, AVC Paz, AA Dargél, M Kunz, ... Current psychiatry reports 14, 667-675, 2012 | 128 | 2012 |
| Relationship between cognitive functioning and 6-month clinical and functional outcome in patients with first manic episode bipolar I disorder IJ Torres, CM DeFreitas, VG DeFreitas, DJ Bond, M Kunz, WG Honer, ... Psychological medicine 41 (5), 971-982, 2011 | 107 | 2011 |
| Serum brain-derived neurotrophic factor (BDNF) is not associated with response to electroconvulsive therapy (ECT): a pilot study in drug resistant depressed patients B Fernandes, CS Gama, R Massuda, M Torres, D Camargo, M Kunz, ... Neuroscience letters 453 (3), 195-198, 2009 | 107 | 2009 |
| The effect of antipsychotics on the cognitive performance of individuals with psychotic disorders: network meta-analyses of randomized controlled trials DP Baldez, TB Biazus, FD Rabelo-da-Ponte, GP Nogaro, DS Martins, ... Neuroscience & Biobehavioral Reviews 126, 265-275, 2021 | 88 | 2021 |
| The association of elevated body mass index with reduced brain volumes in first-episode mania DJ Bond, DJ Lang, MM Noronha, M Kunz, IJ Torres, W Su, WG Honer, ... Biological psychiatry 70 (4), 381-387, 2011 | 78 | 2011 |
| Optimal duration of risperidone or olanzapine adjunctive therapy to mood stabilizer following remission of a manic episode: a CANMAT randomized double-blind trial LN Yatham, S Beaulieu, A Schaffer, M Kauer-Sant'Anna, F Kapczinski, ... Molecular psychiatry 21 (8), 1050-1056, 2016 | 63 | 2016 |
| Impact of sunlight on the age of onset of bipolar disorder M Bauer, T Glenn, M Alda, OA Andreassen, R Ardau, F Bellivier, M Berk, ... Bipolar disorders 14 (6), 654-663, 2012 | 63 | 2012 |
Clarissa S GamaProfessor of Psychiatry, UFRGS在 hcpa.edu.br 的电子邮件经过验证
